Quantum X posts $2.93M loss, warns on going concern
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Quantum X, Inc. (QUTX) reported no revenue and a net loss of $2,927,672 for the nine months ended September 30, 2026, compared with a $1,083,086 loss a year earlier. It used $868,710 in operating cash and had $79,508 cash and a $3,065,331 working-capital deficit at quarter-end. Management said these conditions raise substantial doubt about its ability to continue as a going concern. Quantum X estimates $1,070,000 in cash expenditures over the next 12 months and is discussing private loans and an equity line of credit.
Quantum X is shifting toward AI and quantum-computing software; its Pegasus, Scalova and EntangleX products had not reached a marketable stage. After quarter-end, it signed a binding letter of intent to acquire 80% of UK-based TraderMade Systems from Currency Mountain Holdings, LLC, which is owned by CEO Emil Assentato. Proposed consideration is 550,000,000 QUTX shares at US$0.001 each, alongside the seller’s rights to a GBP £412,162 receivable plus accrued interest. Closing is subject to customary conditions and an independent valuation confirming at least US$550,000 in combined value for the acquired shares and receivable.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- None.
Negative
- Major pointGoing-concern risk: management cites substantial doubt about the company’s ability to continue.
- Major pointNine-month net loss rose: $2.93 million versus $1.08 million in 2025.
- Moderate pointOperating cash use: $868,710, up from $492,840 in 2025.
Filing Explained
At September 30, 2026, another 2,013,730,387 shares were potentially issuable under convertible notes, separate from shares already issued.
This Form 10-Q is the unaudited quarterly report, and it reports Quantum X, Inc.’s share capital and interim results through
Separately, the company says 2,013,730,387 shares issuable on conversion of non-redeemable and convertible promissory notes were excluded from diluted loss per share at September 30 because their effect would have been anti-dilutive; these are potential conversion shares, not shares reported as issued. The July 6 and September 15 notes become convertible at the holder’s option after 180 days, at a price based on
Key Figures
Key Terms
going concern financial
variable conversion price financial
derivative liability financial
anti-dilutive financial
capitalized software development costs technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much revenue and net loss did QUTX report for the first nine months of 2026?
Why did QUTX report substantial doubt about continuing as a going concern?
What are the terms of QUTX’s proposed TraderMade acquisition?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
For the quarterly period ended
OR
For the transition period from _________ to __________
Commission File Number:
(Exact name of registrant as specified in its charter)
| (State or Other Jurisdiction of | (I.R.S. Employer | |
| Incorporation or Organization) | Identification No.) | |
|
(Address of Principal Executive Offices) |
(Zip Code)
| |
(
(Registrant's telephone number, including area code)
(Former name, former address and former fiscal year, if changed since last report)
Indicate
by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the
past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data
File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12
months (or for such shorter period that the registrant was required to submit and post such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.
| Large accelerated filer | ¨ | Accelerated filer | ¨ |
| x | Smaller reporting company | ||
| Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
¨ No
Securities registered under Section 12(b) of the Act:
| Title of each class | Name of each exchange on which registered |
| N/A | N/A |
| 1 |
Securities registered under Section 12(g) of the Act:
(Title of class)
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐
State the number of shares outstanding of each of
the issuer’s classes of common equity, as of the latest practicable date: As of November 11, 2026 the issuer had
| 2 |
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This report on Form 10-Q contains "forward-looking statements" that involve risks and uncertainties. You should not place undue reliance on these forward-looking statements. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons, including the risks described in our Form 10-K filed on April 10, 2026, and other filings we make with the Securities and Exchange Commission. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made. We do not intend to update any of the forward-looking statements after the date of this report to conform these statements to actual results or to changes in our expectations, except as required by law.
The following discussion and analysis of financial condition and results of operations is based upon and should be read in conjunction with our audited financial statements and related notes thereto included in our Form 10-K filed on April 10, 2026.
| 3 |
QUANTUM X, INC.
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED SEPTEMBER 30, 2026
TABLE OF CONTENTS
| PART I | PAGE | |
| Item 1. | Financial Statements (Unaudited) | 5 |
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 21 |
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 30 |
| Item 4. | Controls and Procedures | 30 |
| PART II | ||
| Item 1. | Legal Proceedings | 31 |
| Item 1A. | Risk Factors | 31 |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 31 |
| Item 3. | Defaults Upon Senior Securities | 31 |
| Item 4. | Mining Safety Disclosures | 31 |
| Item 5. | Other Information | 31 |
| Item 6. | Exhibits | 32 |
| Signatures | 33 |
| 4 |
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements.
| QUANTUM X, INC. |
| (FORMERLY KNOWN AS TWO HANDS CORPORATION) |
| CONDENSED CONSOLIDATED BALANCE SHEETS |
| September 30, 2026 | December 31, 2025 | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current assets | ||||||||
| Cash | $ | $ | ||||||
| VAT taxes receivable | ||||||||
| Prepaid expenses | ||||||||
| Total current assets | ||||||||
| Property and equipment, net | ||||||||
| Capitalized software development costs | ||||||||
| Deposits | ||||||||
| Total assets | $ | $ | ||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||
| Current liabilities | ||||||||
| Accounts payable and accrued liabilities | $ | $ | ||||||
| Accrued liabilities - related party | ||||||||
| Note payable - related party | ||||||||
| Notes payable | ||||||||
| Non-redeemable convertible note, net - related party | ||||||||
| Convertible promissory notes, net | ||||||||
| Derivative liabilities | ||||||||
| Total current liabilities | ||||||||
| Total liabilities | ||||||||
| Commitments and Contingencies | — | — | ||||||
| Stockholders' deficit | ||||||||
| Preferred stock; | ||||||||
| Common stock; $ | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated other comprehensive income | ||||||||
| Accumulated deficit | ( | ) | ( | ) | ||||
| Total stockholders' deficit | ( | ) | ( | ) | ||||
| Total liabilities and stockholders' deficit | $ | $ | ||||||
| The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. | ||||||||
| 5 |
| QUANTUM X, INC. |
| (FORMERLY KNOWN AS TWO HANDS CORPORATION) |
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) |
| (Unaudited) |
| For the three months ended September 30, | For the nine months ended September 30, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Revenue | $ | $ | $ | $ | ||||||||||||
| Operating expenses | ||||||||||||||||
| General and administrative | ||||||||||||||||
| Total operating expenses | ||||||||||||||||
| Loss from operations | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Other income (expense) | ||||||||||||||||
| Amortization of debt discount and interest expense | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Gain (loss) on settlement of debt | ( | ) | ( | ) | ||||||||||||
| Initial derivative expense | ( | ) | ( | ) | ||||||||||||
| Change in fair value of derivative liabilities | ||||||||||||||||
| Write-off of advances | ( | ) | ( | ) | ||||||||||||
| Total other income (expense) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Net loss | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Other comprehensive income (loss) | ||||||||||||||||
| Foreign currency translation adjustment | ( | ) | ( | ) | ||||||||||||
| Total other comprehensive income (loss) | ( | ) | ( | ) | ||||||||||||
| Comprehensive loss | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Loss per common share - basic and diluted | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Weighted average number of common shares outstanding - basic and diluted | ||||||||||||||||
| The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. | ||||||||||||||||
| 6 |
| QUANTUM X, INC. |
| (FORMERLY KNOWN AS TWO HANDS CORPORATION) |
| CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT |
| For the three and nine months ended September 30, 2026 and 2025 |
| (Unaudited) |
| Common Stock | Additional Paid-in | Accumulated Other Comprehensive | Accumulated | Total Stockholders' | ||||||||||||||||||||
| Shares | Amount | Capital | Income (Loss) | Deficit | Deficit | |||||||||||||||||||
| Balance, June 30, 2026 | $ | $ | $ | $ | ( | ) | $ | ( | ) | |||||||||||||||
| Stock based compensation - services | $ | — | — | |||||||||||||||||||||
| Stock issued for the settlement of convertible promissory notes | $ | — | — | |||||||||||||||||||||
| Foreign currency translation adjustment | — | — | — | ( | ) | — | ( | ) | ||||||||||||||||
| Net loss | — | — | — | — | ( | ) | ( | ) | ||||||||||||||||
| Balance, September 30, 2026 | $ | $ | $ | $ | ( | ) | $ | ( | ) | |||||||||||||||
| Common Stock | Additional Paid-in | Accumulated Other Comprehensive | Accumulated | Total Stockholders' | ||||||||||||||||||||
| Shares | Amount | Capital | Income (Loss) | Deficit | Deficit | |||||||||||||||||||
| Balance, December 31, 2025 | $ | $ | $ | $ | ( | ) | $ | ( | ) | |||||||||||||||
| Stock based compensation - officers and directors | $ | — | — | |||||||||||||||||||||
| Stock based compensation - services | $ | — | — | |||||||||||||||||||||
| Stock based compensation - prepaid expense | $ | — | — | |||||||||||||||||||||
| Cancellation of shares | ( | ) | $ | ( | ) | — | — | — | ||||||||||||||||
| Settlement of accrued liabilities - related party | $ | — | — | |||||||||||||||||||||
| Stock issued for the settlement of convertible promissory notes | $ | — | — | |||||||||||||||||||||
| Foreign currency translation adjustment | — | — | — | — | ||||||||||||||||||||
| Net loss | — | — | — | — | ( | ) | ( | ) | ||||||||||||||||
| Balance, September 30, 2026 | $ | $ | $ | $ | ( | ) | $ | ( | ) | |||||||||||||||
| Common Stock | Additional Paid-in |
Accumulated Other Comprehensive | Accumulated | Total Stockholders' | ||||||||||||||||||||
| Shares | Amount | Capital | Income (Loss) | Deficit | Deficit | |||||||||||||||||||
| Balance, June 30, 2025 | $ | $ | $ | $ | ( | ) | $ | ( | ) | |||||||||||||||
| Stock issued for the settlement of promissory note | — | — | ||||||||||||||||||||||
| Foreign currency translation adjustment | — | — | — | — | ||||||||||||||||||||
| Net loss | — | — | — | — | ( | ) | ( | ) | ||||||||||||||||
| Balance, September 30, 2025 | $ | $ | $ | $ | ( | ) | $ | ( | ) | |||||||||||||||
| Common Stock | Additional Paid-in |
Accumulated Other Comprehensive | Accumulated | Total Stockholders' | ||||||||||||||||||||
| Shares | Amount | Capital | Income (Loss) | Deficit | Deficit | |||||||||||||||||||
| Balance, December 31, 2024 | $ | $ | $ | $ | ( | ) | $ | ( | ) | |||||||||||||||
| Stock issued for the settlement of promissory note | — | — | ||||||||||||||||||||||
| Stock issued for the settlement of line of credit | — | — | ||||||||||||||||||||||
| Foreign currency translation adjustment | — | — | — | ( | ) | — | ( | ) | ||||||||||||||||
| Net loss | — | — | — | — | ( | ) | ( | ) | ||||||||||||||||
| Balance, September 30, 2025 | $ | $ | $ | $ | ( | ) | $ | ( | ) | |||||||||||||||
| The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. | ||||||||||||||||||||||||
| 7 |
| QUANTUM X, INC. |
| (FORMERLY KNOWN AS TWO HANDS CORPORATION) |
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
| (Unaudited) |
| For the nine months ended September 30, | ||||||||
| 2026 | 2025 | |||||||
| Cash flows from operating activities | ||||||||
| Net loss | $ | ( | ) | $ | ( | ) | ||
| Adjustments to reconcile net loss to cash used in operating activities | ||||||||
| Depreciation - property and equipment | ||||||||
| Amortization - right-of-use asset | — | |||||||
| Bad debt | ||||||||
| Stock based compensation - officers and directors | ||||||||
| Stock based compensation - services | ||||||||
| Stock based compensation - prepaid expense | ||||||||
| Gain on settlement | ( | ) | ||||||
| Write-off of advances | ||||||||
| Amortization of debt discount and interest expense | ||||||||
| Loss on settlement of non-redeemable convertible notes and promissory notes | ||||||||
| Initial derivative expense | ||||||||
| Change in fair value of derivative liabilities | ( | ) | ( | ) | ||||
| Change in operating assets and liabilities | ||||||||
| Accounts and taxes receivable | ( | ) | ||||||
| Prepaid expense | ( | ) | ( | ) | ||||
| Accounts payable and accrued liabilities | ||||||||
| Operating lease right-of-use liability | ( | ) | ||||||
| Net cash used in operating activities | ( | ) | ( | ) | ||||
| Cash flows from investing activities | ||||||||
| Purchase of fixed assets | ( | ) | ||||||
| Software development costs | ( | ) | ||||||
| Deposits | ( | ) | ||||||
| Return of deposits | ||||||||
| Net cash used in investing activities | ( | ) | ||||||
| Cash flow from financing activities | ||||||||
| Advances | ||||||||
| Repayment of advances | ( | ) | ||||||
| Advances - related party | ||||||||
| Expenses paid for by related party | ||||||||
| Issuance of promissory note, net | ||||||||
| Issuance of convertible promissory note, net | ||||||||
| Repayment of convertible promissory notes | ( | ) | ||||||
| Net cash provided by financing activities | ||||||||
| Change in foreign exchange | ||||||||
| Net change in cash | ( | ) | ||||||
| Cash, beginning of the period | ||||||||
| Cash, end of the period | $ | $ | ||||||
| Cash paid during the period | ||||||||
| Interest paid | $ | $ | ||||||
| Income taxes paid | $ | $ | ||||||
| Supplemental disclosure of non-cash investing and financing activities | ||||||||
| Stock issued for the settlement of line of credit | $ | $ | ||||||
| Stock issued for the settlement of promissory notes | $ | $ | ||||||
| Stock issued for settlement of accrued liabilities - related party | $ | $ | ||||||
| Stock issued for the settlement of convertible promissory notes | $ | $ | ||||||
The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. | ||||||||
| 8 |
QUANTUM X, INC.
(FORMERLY KNOWN AS TWO HANDS CORPORATION)
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 1 - NATURE OF OPERATIONS AND BASIS OF PRESENTATION
Quantum X, Inc. (the "Company") was incorporated in the state of Delaware on April 3, 2009. On July 26, 2016, the Company changed its name from Innovative Product Opportunities Inc. to Two Hands Corporation and on September 14, 2026 the Company changed its name from Two Hands Corporation to Quantum X, Inc.
The Two Hands co-parenting application launched on July 2018 and the Two Hands Gone application launched In February 2019. The Company ceased work on these applications in 2021.
The Company is currently in the process of shifting its focus to becoming a technology company, specifically in the artificial intelligence and quantum computing spaces. The Company’s AI strategy is to address the needs of three distinct economies, each of which requires a different solution: personal AI, enterprise automation, and compute frontier through a portfolio of three products: Pegasus, Scalova, and EntangleX.
On June 30, 2026, pursuant to stockholder consent, our Board of Directors authorized an amendment (the “Amendment”) to our Certificate of Incorporation, as amended, to change the name of the Corporation from Two Hands Corporation to Quantum X, Inc. The Company filed the Amendment with the Delaware Secretary of State on July 8, 2026. On September 11, 2026, FINRA announced the name change, together with a change of the Company’s trading symbol from “TWOH” to “QUTX”, on its Daily List. The name change and the symbol change became effective on September 14, 2026. The Company’s common stock now trades under the symbol “QUTX.”
On July 7, 2026, the Company voluntarily delisting its common shares from the Canadian Securities Exchange (the "CSE"). The Company’s common shares are no longer listed or posted for trading on the CSE. The Company’s common stock continues to be quoted on the OTC Markets under the symbol “QUTX”.
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
BASIS OF PRESENTATION
The accompanying condensed consolidated financial statements of Quantum X, Inc. have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission requirements for interim financial statements. Therefore, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. The financial statements should be read in conjunction with the annual financial statements for the year ended December 31, 2025 of Quantum X, Inc. in our Form 10-K filed on April 10, 2026.
The interim financial statements present the balance sheets, statements of operations, stockholders’ deficit and cash flows of Quantum X, Inc. The financial statements have been prepared in accordance with accounting principles generally accepted in the United States.
The interim financial information is unaudited. In the opinion of management, all adjustments necessary to present fairly the financial position as of September 30, 2026 and the results of operations and cash flows presented herein have been included in the financial statements. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results of operations for the full year.
GOING CONCERN
The Company's financial statements are prepared
in accordance with generally accepted accounting principles applicable to a going concern. This contemplates the realization of
assets and the liquidation of liabilities in the normal course of business. During the nine months ended September 30, 2026, the
Company incurred a net loss of $
| 9 |
PRINCIPLES OF CONSOLIDATION
The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Two Hands Canada Corporation and Meridian Capital Management Inc. All intercompany transactions and balances have been eliminated in consolidation.
USE OF ESTIMATES AND ASSUMPTIONS
Preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.
CASH AND CASH EQUIVALENTS
For the purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents.
ACCOUNTS RECEIVABLE
Trade accounts receivable is recorded at the invoiced amount and do not bear interest. The Company grants credit to its customers with defined payment terms, performs ongoing evaluations of the credit worthiness of its customers and generally does not require collateral. Accounts receivables are carried at their outstanding principal amounts, less an anticipated amount for discounts and an allowance for expected credit losses, which management believes is sufficient to cover potential credit losses based on historical experience and periodic evaluation of the financial condition of the Company's customers. Estimated credit losses consider relevant information about past events, current conditions and reasonable and supporting forecasts that affect the collectability of financial assets.
The allowance for doubtful accounts on September 30,
2026 and December 31, 2025 is $
PROPERTY AND EQUIPMENT
Property and equipment is stated at cost, less accumulated depreciation and amortization. Expenditures for maintenance and repairs are charged to expense when incurred, while renewals and betterments that materially extend the life of an asset are capitalized.
The costs of assets sold, retired, or otherwise disposed of, and the related allowance for depreciation, are eliminated from the accounts, and any resulting gain or loss is recognized in the results from operations. Depreciation is provided over the estimated useful lives of the assets, which are as follows:
Graphics Processing Unit (GPU)
straight line over
Computer equipment
REVENUE RECOGNITION
In accordance with Accounting Standards Codification (“ASC”) 606, revenue is recognized when a customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which we expect to be entitled to receive in exchange for these goods or services. The provisions of ASC 606 include a five-step process by which we determine revenue recognition, depicting the transfer of goods or services to customers in amounts reflecting the payment to which we expect to be entitled in exchange for those goods or services. ASC 606 requires us to apply the following steps: (1) identify the contract with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, we satisfy the performance obligation.
DEBT DISCOUNT AND DEBT ISSUANCE COSTS
Debt discounts and debt issuance costs incurred in connection with the issuance of convertible notes are capitalized and amortized to interest expense based on the related debt agreements using the effective interest rate method. Unamortized discounts are netted against convertible notes.
| 10 |
DERIVATIVE LIABILITIES
The Company evaluates the embedded features of its financial instruments, including convertible notes payable, in accordance with ASC 480, “Distinguishing Liabilities from Equity,” and ASC 815, “Derivatives and Hedging.” Certain conversion options and certain contingent features are required to be bifurcated from their host instrument and accounted for separately as derivative financial instruments when applicable criteria are met. The Company applies significant judgment to identify and evaluate complex terms and conditions of its financial instruments to determine whether such instruments are derivatives or contain features that qualify as embedded derivatives.
Bifurcated embedded derivatives are recognized at fair value at issuance, with the fair value recorded as a derivative liability and a corresponding debt discount limited to the proceeds received; any excess of the derivative’s fair value over the proceeds is recognized in the condensed consolidated statements of operations at issuance. Debt discounts are amortized to interest expense over the term of the related note. Bifurcated embedded derivatives are remeasured to fair value each reporting period, with changes in fair value recognized in the condensed consolidated statements of operations. Upon conversion, repayment, or extinguishment of the host instrument, the related derivative liability is remeasured to fair value with the change recognized in earnings and is then derecognized as part of the settlement or extinguishment accounting.
The fair value of bifurcated embedded derivatives is estimated using a Monte Carlo simulation model incorporating significant unobservable inputs, and such measurements are classified within Level 3 of the fair value hierarchy.
INCOME TAXES
The Company accounts for income taxes in accordance with ASC") 740, Income Taxes. Under the assets and liability method of ASC 740, deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.
NET LOSS PER SHARE
Basic net income (loss) per share includes no dilution
and is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding
for the period. Diluted earnings per share is computed by dividing earnings available to common shareholders by the weighted average number
of common shares outstanding for the period increased to include the number of additional common shares that would have been outstanding
if potentially dilutive securities had been issued. Dilutive net loss per share for common stock is calculated utilizing the if-converted
method which assumes the conversion non-redeemable convertible notes and the line of credit. On September 30, 2026, we excluded the common
stock issuable upon conversion of non-redeemable convertible notes and convertible promissory notes of
FOREIGN CURRENCY TRANSLATION
The consolidated financial statements are presented in United States dollars. The functional currency of the consolidated entities is determined by evaluating the economic environment of each entity. The functional currency of Quantum X, Inc. is the United States dollar. Foreign exchange translation adjustments are reported as gains or losses resulting from foreign currency transactions and are included in the results of operations.
Two Hands Canada Corporation maintains its accounts in the Canadian dollar. Assets and liabilities are translated to United States dollars at period-end exchange rates. Income and expenses are translated at the average exchange rate during the period. Foreign currency transaction adjustments are reported as other comprehensive income, a component of equity in the consolidated statements of stockholders’ deficit.
STOCK-BASED COMPENSATION
The Company accounts for stock incentive awards issued to employees and non-employees in accordance with ASC 718, “Compensation—Stock Compensation.” Accordingly, stock-based compensation is measured at the grant date, based on the fair value of the award. Stock-based awards to employees are recognized as an expense over the requisite service period, or upon the occurrence of certain vesting events. Additionally, stock-based awards to non-employees are expensed over the period in which the related services are rendered.
| 11 |
FAIR VALUE OF FINANCIAL INSTRUMENTS
ASC 820, “Fair Value Measurements,” defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.
Included in the ASC 820 framework is a three level valuation inputs hierarchy with Level 1 being inputs and transactions that can be effectively fully observed by market participants spanning to Level 3 where estimates are unobservable by market participants outside of the Company and must be estimated using assumptions developed by the Company. The Company discloses the lowest level input significant to each category of asset or liability valued within the scope of ASC 820 and the valuation method as exchange, income or use. The Company uses inputs which are as observable as possible and the methods most applicable to the specific situation of each company or valued item.
The Company’s financial instruments such as cash, accounts payable and accrued liabilities, non-redeemable convertible notes, notes payable and due to related parties are reported at cost, which approximates fair value due to the short-term nature of these financial instruments.
The fair value of financial instruments measured at fair value on a recurring basis as of September 30, 2026 and December 31, 2025 consisted of the following:
| Schedule of fair value on a recurring basis | ||||||||||||
| September 30, 2026 | ||||||||||||
| Level 1 | Level 2 | Level 3 | ||||||||||
| Description | $ | $ | $ | |||||||||
| Derivative liabilities | ||||||||||||
| December 31, 2025 | ||||||||||||
| Level 1 | Level 2 | Level 3 | ||||||||||
| Description | $ | $ | $ | |||||||||
| Derivative liabilities | ||||||||||||
The following table presents changes in the Company’s Level 3 derivative liabilities measured at fair value on a recurring basis:
| Schedule of derivative liabilities measured at fair value | ||||
| Amount | ||||
| Derivative Liabilities | ||||
| Balance as of December 31, 2025 | $ | |||
| Initial fair value of embedded derivative liability upon issuance of convertible note (limited to proceeds) | ||||
| Initial derivative expense upon issuance of convertible note (in excess of proceeds) | ||||
| Extinguishment of derivative liabilities upon repayment of convertible notes | ( | ) | ||
| Gain on change in fair value of derivative liabilities | ( | ) | ||
| Balance as of September 30, 2026 | $ | |||
| Balance as of December 31, 2024 | $ | |||
| Initial fair value of embedded derivative liability upon issuance of convertible note (limited to proceeds) | ||||
| Initial derivative expense upon issuance of convertible note (in excess of proceeds) | ||||
| Gain on change in fair value of derivative liabilities | ( | ) | ||
| Balance as of September 30, 2025 | $ |
RECENT ACCOUNTING PRONOUNCEMENTS
Recently Adopted
In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-04, “Debt—Debt with Conversion and Other Options,” which clarifies the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. The new guidance is effective for annual reporting periods beginning after December 15, 2025 and can be applied either prospectively or retrospectively. The adoption of ASU 2024-04 did not have a material impact on the Company’s condensed consolidated financial statements.
| 12 |
In July 2025, the FASB issued ASU 2025-05, “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets,” which introduces a practical expedient for the application of the current expected credit loss model to current accounts receivable and contract assets. The amendment is effective for interim and annual periods beginning after December 15, 2025, with early adoption permitted. This amendment is to be applied on a prospective basis. The adoption of ASU 2025-05 did not have a material impact on the Company’s condensed consolidated financial statements.
Recently Issued — Not Yet Adopted
In November 2024, the FASB issued ASU 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses,” which requires disaggregated disclosure of specific expense categories, including purchases of inventory, employee compensation, depreciation, and amortization included in each relevant expense caption presented on the statement of operations. The standard also requires a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively, as well as the total amount of selling expenses and an entity’s definition of selling expenses. ASU 2024-03 is effective for annual periods beginning after December 15, 2026, and interim periods within annual periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact this standard will have on its condensed consolidated financial statements.
In October 2023, the FASB issued ASU 2023-06, “Disclosure Improvements — Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative.” The ASU amends the disclosure or presentation requirements related to various subtopics in the FASB ASC. The ASU was issued in response to the SEC’s August 2018 final amendments in Release No. 33-10532, Disclosure Update and Simplification that updated and simplified disclosure requirements that the SEC believed were duplicative, overlapping, or outdated. The guidance in ASU 2023-06 is intended to align GAAP requirements with those of the SEC and to facilitate the application of GAAP for all entities. The amendments introduced by ASU 2023-06 are effective if the SEC removes the related disclosure or presentation requirement from its existing regulations by June 30, 2027. If, by June 30, 2027, the SEC has not removed the applicable requirements from its existing regulations, the pending content of the associated amendment will be removed from the ASC and will not become effective for any entities. The Company is currently evaluating the impact this standard will have on its condensed consolidated financial statements.
In December 2025, the FASB issued ASU 2025-11, “Interim Reporting (Topic 270): Narrow-Scope Improvements.” ASU 2025-11 clarifies and improves existing interim reporting guidance by consolidating disclosure requirements within Topic 270 and introducing a disclosure principle requiring entities to disclose events and changes occurring after the most recent annual reporting period that are expected to have a material effect on the entity’s financial condition or results of operations. The ASU does not introduce significant changes to recognition or measurement guidance. The amendments in ASU 2025-11 are effective for interim reporting periods within fiscal years beginning after December 15, 2027, with early adoption permitted. ASU 2025-11 allows for either a prospective or retrospective approach on adoption. The Company is currently evaluating the impact this standard will have on its condensed consolidated financial statements.
Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.
NOTE 3 – PROPERTY AND EQUIPMENT
| Schedule of property and equipment | ||||||||||||||||
| Cost | Accumulated Depreciation | September 30, 2026 Net Book Value | December 31, 2025 Net Book Value | |||||||||||||
| Graphics Processing Unit (GPU) | $ | $ | $ | $ | ||||||||||||
| Computer | ||||||||||||||||
| $ | $ | $ | $ | |||||||||||||
Depreciation expense for nine months ended September
30, 2026 and 2025 was $
| 13 |
NOTE 4 – CAPITALIZED SOFTWARE DEVELOPMENT COSTS
The Company capitalizes costs incurred to develop software for internal use, including software that will be used to provide a hosted service to customers who will not take possession of the software, in accordance with ASC 350-40, Intangibles—Goodwill and Other—Internal-Use Software. Costs incurred during the preliminary project stage are expensed as incurred. Capitalization begins when the preliminary project stage is complete, management with the relevant authority has authorized and committed to funding the project, and it is probable that the project will be completed and the software will be used to perform the function intended. Costs incurred during the post-implementation stage, including training and routine maintenance, are expensed as incurred. Costs of upgrades and enhancements are capitalized only when it is probable that the expenditures will result in additional functionality.
In August 2026, the Company concluded that the foregoing
criteria had been met with respect to Scalova, its enterprise automation product, and began capitalizing application development stage
costs incurred after that date. The Company capitalized $20,000 of such costs during the three months ended September 30, 2026. Capitalized
software development costs were $
The Scalova software was not ready for its intended use at September 30, 2026 and, accordingly, no amortization has been recorded. Amortization will commence when the software is ready for its intended use and will be recognized on a straight-line basis over the estimated useful life of the software.
Capitalized software development costs are reviewed for impairment in accordance with ASC 360-10 whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. No impairment charge was recorded during the three or nine months ended September 30, 2026.
Costs incurred during the three and nine months ended September 30, 2026 with respect to the Company’s Pegasus and EntangleX products did not meet the criteria for capitalization and were expensed as incurred within general and administrative expense.
NOTE 5 – NON-REDEEMABLE CONVERTIBLE NOTE, NET – RELATED PARTY
On December 30, 2024, Jordan Turk and the Company
agreed to exchange $
Also, on December 30, 2024, Jordan Turk entered into
an agreement to assign the remaining outstanding principal and interest of the Original Note with a carrying value of $
The consolidated statement of operations includes
amortization of debt discount of $
NOTE 6 – NOTES PAYABLE
As of September 30, 2026 and December 31, 2025, notes
payable due to Piero Manzini and Nadav Elituv, the former CEO of the Company, totaling $
NOTE 7 – CONVERTIBLE PROMISSORY NOTES, NET
Vanquish Funding Group, Inc.
On November 13, 2025, the
Company entered into a Securities Purchase Agreement with Vanquish Funding Group, Inc. (“Holder”) relating to the issuance
and sale of a Convertible Note (the “Note”) with an original principal amount of $
| 14 |
On December 2, 2025,
the Company entered into a Securities Purchase Agreement with Vanquish Funding Group, Inc. (“Holder”) relating to the
issuance and sale of a Convertible Note (the “Note”) with an original principal amount of $
On January 16, 2026, the
Company entered into a Securities Purchase Agreement with Vanquish Funding Group, Inc. (“Holder”) relating to the issuance
and sale of a Convertible Note (the “Note”) with an original principal amount of $
On July 6, 2026, the Company
entered into a Securities Purchase Agreement with the Holder relating to the issuance and sale of a convertible promissory note (the “Note”)
with an original principal amount of $
On September 15, 2026, the
Company entered into a Securities Purchase Agreement with the Holder relating to the issuance and sale of a convertible promissory note
(the “Note”) with an original principal amount of $
Vanquish Funding Group, Inc. – Modified Promissory Note
In July 17, 2026, the Company and the Holder amended the promissory note ( the “New Note”) issued May 20, 2026 to, among other things, (i) convert the note from an instrument convertible only upon an Event of Default into a note that is convertible into shares of common stock of the borrower at the Holder’s election on the terms set forth below (ii) provide for a variable conversion price consistent with the terms of the convertible promissory note issued by the borrower to the Holder dated July 6, 2026 (that is, a variable conversion price calculated as 75% of the average of the three lowest closing bid prices during the ten trading days prior to the conversion date) (iii) replace the scheduled payments with a single payment of principal and interest at maturity and (iv) replace the tiered prepayment discount schedule with a flat prepayment percentage consistent with the terms of the July 6, 2026 note (that is, the Company may prepay the Note in cash, within 180 days of the issue date, at 125% of the outstanding principal amount plus accrued and unpaid interest; no prepayment is permitted after 180 days from the issue date).
| 15 |
The original terms of the May 20, 2026 before the amendment on July 17,2026 is as follows:
On May 20, 2026, the Company entered into
a Securities Purchase Agreement with Vanquish Funding Group, Inc. (“Holder”) relating to the issuance and sale of a promissory
note (the “Note”) with an original principal amount of $
The amendment to the promissory note on July 17, 2026
is accounted for as a modification on a prospective basis with no gain or loss recorded. The Company evaluated the embedded conversion
feature of the New Note for bifurcation under ASC 815-15 and, as such, recorded a derivative liability on July 17, 2026 with a fair value
of $
On September 30, 2026 the New Note was recorded at
amortized cost of $
NOTE 8 - DERIVATIVE LIABILITY
The Convertible Promissory Notes with Vanquish Funding Group, Inc. with issue and modification dates of November 13, 2025, December 2, 2025, January 16, 2026, July 6, 2026, July 17, 2026 and September 15, 2026 are accounted for under ASC 815. Because the conversion price varies with the market price of the Company’s common stock, the conversion feature is not considered indexed to the Company’s own stock and does not qualify for the scope exception in ASC 815-40; accordingly, the conversion feature is bifurcated from the debt host and accounted for as a derivative liability. The Company’s derivative liabilities have been measured at fair value using the Monte Carlo simulation model starting June 30, 2026 and binomial model at all other periods (the “fair value models”). The Company changed its valuation technique to a Monte Carlo simulation model on June 30, 2026 to better reflect the path-dependent conversion price mechanics of the notes; the change is accounted for prospectively as a change in accounting estimate.
The inputs into the fair value models are as follows:
| Schedule of derivative liabilities fair value | ||||||
| September 30, 2026 | September 15, 2026 | July 17, 2027 | July 6, 2026 | June 30, 2026 | March 31, 2026 | |
| Stock price | $ |
$ |
$ |
$ |
$ |
$ |
| Conversion price | $ |
$ |
$ |
$ |
$ |
$ |
| Risk-free rate | ||||||
| Expected volatility | ||||||
| Dividend yield | ||||||
| Expected life |
| 16 |
| January 16, 2026 | December 31, 2025 | December 2, 2025 | November 13, 2025 | |||||||||||||
| Stock price | $ | $ | $ | $ | ||||||||||||
| Conversion price | $ | $ | $ | $ | ||||||||||||
| Risk-free rate | % | % | % | % | ||||||||||||
| Expected volatility | % | % | % | % | ||||||||||||
| Dividend yield | % | % | % | % | ||||||||||||
| Expected life | ||||||||||||||||
NOTE 9 – RELATED PARTY TRANSACTIONS
Notes payable – related party
On September 30, 2026 and December 31, 2025, $
Employment Agreements
During the nine months ended September 30, 2026 and
2025, compensation expenses of $
Software Development Agreement
On May 1, 2026, the Company
entered into an agreement with Ujjwal Roy, the Head of Strategy of the Company, under which Mr. Roy agreed to (a) complete the build-out
of the user interface for EntangleX and (b) provide ongoing maintenance, operations, marketing, sales and engineering services (“monthly
operating costs”) for EntangleX and Scalova. The Company committed to $
During the three and nine months
ended September 30, 2026, the Company paid $
The Company accounts for the
costs of developing these products in accordance with ASC 350-40, as the software will be hosted on the Company’s servers and customers
will not take possession of the software. Of the $
At September 30, 2026, $
Settlement of Accrued Liabilities
During the nine months ended September 30, 2026, the
Company issued
NOTE 10 - STOCKHOLDERS' EQUITY
The Company is authorized to issue an aggregate of
Preferred Stock
On August 6, 2013, the Company filed a
Certificate of Designation with the Delaware Secretary of State thereby designating two hundred thousand (
| 17 |
On December 12, 2019, the Company filed a Certificate
of Designation with the Delaware Secretary of State thereby designating one hundred thousand (
On October 7, 2020, the Company filed a Certificate
of Designation with the Delaware Secretary of State thereby designating five thousand (
On September 1, 2021, the Company filed a Certificate
of Designation with the Delaware Secretary of State thereby designating two hundred thousand (
On October 4,
2022, the Company filed a Certificate of Designation with the Delaware Secretary of State that had the effect of designating
Common Stock
During the nine months ended September 30, 2026, the
Company issued an aggregate of
During the nine months ended September 30, 2026, the
Company issued an aggregate of
During the nine months ended September 30, 2026, the
Company issued
During the nine months ended September 30, 2026, the
Company returned to treasury and cancelled
During the nine months ended September 30, 2026, the
Company issued
| 18 |
During the nine months ended September 30, 2026, the
Company issued
2026 Stock Incentive Plan
On March 6, 2026, the Board of Directors approved
the 2026 Stock Incentive Plan (the “2026 Plan”) to attract and retain the best available personnel, to provide additional
incentive to employees, directors and consultants, and to promote the success of the Company's business. Pursuant to the 2026 Plan, the
Board may grant incentive stock options, non-qualified stock options, stock appreciation rights, restricted shares and restricted share
units. to eligible persons. The maximum aggregate number of shares of common stock with respect to which awards granted under the Plan
shall not exceed
NOTE 11 – SEGMENT REPORTING
Operating segments are defined as components of an entity for which separate discrete financial information is available and is regularly evaluated by the chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company has one reportable segment: the development of artificial intelligence and quantum computing software products. The Company’s CODM is Emil Assentato, President, Chief Executive Officer and Director.
The CODM assesses the performance of the segment and decides how to allocate resources based on consolidated general and administrative expenses and consolidated net loss, which the CODM reviews against prior quarters and against the Company’s operating budget. Discrete financial information is not prepared or reviewed below the consolidated level, and accordingly the measure of segment profit or loss is consolidated net loss as reported in the condensed consolidated statements of operations and comprehensive income (loss).
The Company generated no revenue during the three and nine months ended September 30, 2026 and 2025, has incurred losses, and expects to continue to incur losses as it develops its Pegasus, Scalova, and EntangleX products, none of which has reached a marketable stage. The CODM uses cash forecasts, together with the expected timing and cost of completing each product under development, in deciding how to allocate the Company’s available funds among those products and in determining the timing and amount of advances from the Chief Executive Officer and other financings. Total segment assets are the same as total consolidated assets.
NOTE 12 – COMMITMENTS
Software Development Agreement
On May 1, 2026, the Company
entered into a contract with Ujjwal Roy, the Head of Strategy of the Company, to (a) complete the build-out of the user face for EntangleX
and (b) provide ongoing maintenance, operations, marketing, sales, and engineering services (“monthly operating costs”) to
EntangleX and Scalova. The Company is committed to $
Deposits
On July 14, 2025, the Company entered into a definitive
agreement with More Capital Ltd. The purpose of the definitive agreement is to incorporate a new holding company to operate a confection
brand and operating company. The definitive agreement includes conditions precedent for the Company to issue
| 19 |
On July 28, 2025, the Company entered into a definitive agreement with More Money Ltd. The definitive agreement provides that More Money Ltd. will receive 110,000,000 shares of the Company’s common stock and the Company will transfer $200,000 of cash to More Money Ltd. The CEO transferred 110,000,000 personal shares to satisfy the equity portion of the consideration, and the Company paid $15,992 net advances ($120,000 cash advanced by the Company less repayment from More Money Ltd. of $104,008) and $60,000 in cash at September 30, 2026 and December 31, 2025, respectively. At September 30, 2026, the Company recorded a write-off of advances of $15,992 as the remaining portion of the net advances are not recoverable. On September 30, 2026 and December 31, 2025, $0 and $60,000 are recorded as a deposit on the consolidated balance sheets, respectively.
Deposit on Pending IP License Acquisition
On January 23, 2026, the Company entered into an agreement with OnGraph Technologies Limited and/or its affiliates, including DailyLove (collectively “DailyLove”) whereby DailyLove agreed to provide the Company with (i) a license in 100% of the intellectual property (including all software, source code, data, models and documentation) assets related to the AI dating platform (DAILYLOVE.AI) (the” IP Assets”) and (ii) issue a certain number of shares of common stock of DailyLove, all pursuant to terms and conditions of this agreement (“Equity Contingency Consideration”).
NOTE 13 – SUBSEQUENT EVENTS
TraderMade Systems Ltd. – Binding Letter of Intent – Related Party Transaction
On October 5, 2026, the Company announced the execution
of a binding letter of intent (the "LOI") to acquire an
| 20 |
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Management's Plan of Operation
In June 2025, the Company announced, after fully evaluating the legacy business, the Company is taking steps to reinvigorate it and establish a new pathway in the same business space. The Company will continue to evaluate opportunities both inside and outside the food industry, including, but not limited to, ventures within the fintech and gig economy spaces.
The Company is currently in the process of shifting its focus to becoming a technology company, specifically in the artificial intelligence and quantum computing spaces. The Company’s AI strategy is to address the needs three distinct economies, each of which requires a different solution: personal AI, enterprise automation, and compute frontier through a portfolio of three products: Pegasus, Scalova, and EntangleX.
On September 30, 2026, pursuant to stockholder consent, our Board of Directors authorized an amendment (the “Amendment”) to our Certificate of Incorporation, as amended, to change the name of the Corporation from Quantum X, Inc. to Quantum X, Inc. The Company filed the Amendment with the Delaware Secretary of State on July 8, 2026. The name change will not be effective until it is cleared by the Financial Industry Regulatory Authority (“FINRA”).
On July 7, 2026, the Company voluntarily delisting its common shares from the Canadian Securities Exchange (the "CSE"). The Company’s common shares are no longer listed or posted for trading on the CSE. The Company’s common stock continues to be quoted on the OTC Markets under the symbol “QUTX”.
Critical Accounting Policies and Estimates
The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the Financial Statements and accompanying notes. Estimates are used for, but not limited to, the accounting for the allowance for doubtful accounts, impairment of long-term assets, stock-based compensation, derivatives, income taxes and loss contingencies. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates under different assumptions or conditions.
We believe the following critical accounting policies, among others, may be impacted significantly by judgment, assumptions and estimates used in the preparation of the Financial Statements:
NET LOSS PER SHARE
Basic net income (loss) per share includes no dilution and is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of common shares outstanding for the period increased to include the number of additional common shares that would have been outstanding if potentially dilutive securities had been issued. Dilutive net loss per share for common stock is calculated utilizing the if-converted method which assumes the conversion non-redeemable convertible notes and the line of credit. On September 30, 2026, we excluded the common stock issuable upon conversion of non-redeemable convertible notes and convertible promissory notes of 2,013,730,387 shares as their effect would have been anti-dilutive. On September 30, 2025, we excluded the common stock issuable upon conversion of non-redeemable convertible notes and convertible notes of 1,301,143,126 shares as their effect would have been anti-dilutive.
STOCK-BASED COMPENSATION
The Company accounts for stock incentive awards issued to employees and non-employees in accordance with ASC 718, “Compensation—Stock Compensation.” . Accordingly, stock-based compensation is measured at the grant date, based on the fair value of the award. Stock-based awards to employees are recognized as an expense over the requisite service period, or upon the occurrence of certain vesting events. Additionally, stock-based awards to non-employees are expensed over the period in which the related services are rendered.
| 21 |
DERIVATIVE LIABILITY
The Company evaluates the embedded features of its financial instruments, including convertible notes payable, in accordance with ASC 480, “Distinguishing Liabilities from Equity,” and ASC 815, “Derivatives and Hedging.” Certain conversion options and certain contingent features are required to be bifurcated from their host instrument and accounted for separately as derivative financial instruments when applicable criteria are met. The Company applies significant judgment to identify and evaluate complex terms and conditions of its financial instruments to determine whether such instruments are derivatives or contain features that qualify as embedded derivatives.
Bifurcated embedded derivatives are recognized at fair value at issuance, with the fair value recorded as a derivative liability and a corresponding debt discount limited to the proceeds received; any excess of the derivative’s fair value over the proceeds is recognized in the condensed consolidated statements of operations at issuance. Debt discounts are amortized to interest expense over the term of the related note. Bifurcated embedded derivatives are remeasured to fair value each reporting period, with changes in fair value recognized in the condensed consolidated statements of operations. Upon conversion, repayment, or extinguishment of the host instrument, the related derivative liability is remeasured to fair value with the change recognized in earnings and is then derecognized as part of the settlement or extinguishment accounting.
The fair value of bifurcated embedded derivatives is estimated using a Monte Carlo simulation model incorporating significant unobservable inputs, and such measurements are classified within Level 3 of the fair value hierarchy.
COMPARISON OF RESULTS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026 and 2025
Operating expenses:
| Three months ended September 30, | Change | |||||||||||||||
| 2026 $ | 2025 $ | $ | % | |||||||||||||
| Salaries and benefits | 79,500 | 82,917 | (3,417 | ) | (4 | ) | ||||||||||
| Occupancy expense | — | 10 | (10 | ) | (100 | ) | ||||||||||
| Advertising and travel | (6 | ) | — | (6 | ) | |||||||||||
| Auto expenses | — | 983 | (983 | ) | (100 | ) | ||||||||||
| Consulting | 281,777 | 67,506 | 214,271 | 317 | ||||||||||||
| Depreciation and Amortization | 1,555 | 1,990 | (435 | ) | (22 | ) | ||||||||||
| Bad debt | — | 51 | (51 | ) | (100 | ) | ||||||||||
| Office and general expenses | 42,065 | 35,723 | 6,342 | 18 | ||||||||||||
| Professional fees | 32,150 | 70,797 | (38,647 | ) | (55 | ) | ||||||||||
| Stock based compensation - services | 122,633 | — | 122,633 | |||||||||||||
| Total operating expenses | 559,674 | 259,977 | 299,697 | 115 | ||||||||||||
Our total operating expenses for the three months ended September 30, 2026 was $559,674, compared to $259,977, for the three months ended September 30, 2025, respectively. The increase in total operating expense is primarily due to increase in salaries and benefits, consulting, office and general expenses and stock based compensation.
Salaries and benefits for the three months ended September 30, 2026 and 2025, comprise primarily compensation of our officers, directors, and contractor of $79,500 and $82,917, respectively.
During the three months ended September 30, 2026 and 2025, consulting expenses of $281,777 and $67,506 consisted of costs related to the development of new businesses including consulting fees paid to Ujjwal Roy, ExtangleX build out costs and Extangle X monthly operating costs.
Professional fees comprise legal fees from compliance and the review of proposed transactions and debt agreements, annual audit and filling fees.
Stock-based compensation - services for the three months ended September 30, 2026 and 2025, comprise primarily compensation of our contractors of $122,633 and $0, respectively.
| 22 |
Other income (expense):
| Three months ended September 30, | Change | |||||||||||||||
| 2026 $ | 2025 $ | $ | % | |||||||||||||
| Amortization of debt discount and interest expense | (109,763 | ) | (183,629 | ) | 73,866 | (40 | ) | |||||||||
| Loss on settlement of non-redeemable convertible notes and promissory notes | — | (17,181 | ) | (49,003 | ) | (100 | ) | |||||||||
| Write-off of advances | (15,992 | ) | — | (15,992 | ) | |||||||||||
| Change in fair value of derivative liabilities | 8,400 | 44,451 | (36,051 | ) | (81 | ) | ||||||||||
| Total other income (expenses) | (117,355 | ) | (156,359 | ) | 39,004 | (25 | ) | |||||||||
Amortization of debt discount and interest expense for the three months ended September 30, 2026 was $109,763, compared to $183,629 for the three months ended September 30, 2025. Amortization of debt discount and interest expense relates to the issuance of non-redeemable convertible notes, convertible notes and promissory notes. During the year ended December 31, 2025, the Company issued shares of common to stock to settle convertible notes, promissory notes and a line of credit which resulted in a decrease in amortization of debt discount and interest expense during three months ended September 30, 2026.
Net loss for the period:
| Three months ended September 30, | Change | |||||||||||||||
| 2026 $ | 2025 $ | $ | % | |||||||||||||
| Net loss for the period | (677,029 | ) | (416,336 | ) | (260,693) | 63 | ||||||||||
Our net loss for the three months ended September 30, 2026 was $677,029, compared to $416,336 for the three months ended September 30, 2025, respectively. Our losses during the three months ended September 30, 2026 and 2025 are primarily due to costs associated with compensation to our officers and directors, consulting, professional fees, stock based compensation, interest, offset by a decrease in fair value of derivative liabilities.
| 23 |
COMPARISON OF RESULTS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2026 and 2025
Operating expenses:
| Nine months ended September 30, | Change | |||||||||||||||
| 2026 $ | 2025$ | $ | % | |||||||||||||
| Salaries and benefits | 238,500 | 212,917 | 25,583 | 12 | ||||||||||||
| Occupancy expense | — | 1,287 | (1,287 | ) | (100 | ) | ||||||||||
| Advertising and travel | 1,123 | — | 1,123 | |||||||||||||
| Auto expenses | — | 983 | (983 | ) | (100 | ) | ||||||||||
| Consulting | 539,143 | 101,458 | 437,685 | 431 | ||||||||||||
| Depreciation and Amortization | 2,273 | 7,941 | (5,668 | ) | (71 | ) | ||||||||||
| Bad debt | — | 6,611 | (6,611 | ) | (100 | ) | ||||||||||
| Office and general expenses | 130,998 | 68,461 | 62,537 | 91 | ||||||||||||
| Professional fees | 228,841 | 324,990 | (96,149 | ) | (30 | ) | ||||||||||
| Stock based compensation | 773,415 | — | 773,415 | |||||||||||||
| Stock based compensation-salaries | 957,500 | — | 957,500 | |||||||||||||
| Total operating expenses | 2,871,793 | 724,648 | 2,147,145 | 296 | ||||||||||||
Our total operating expenses for the nine months ended September 30, 2026 was $2,871,793, compared to $724,648, for the nine months ended September 30, 2025, respectively. The increase in total operating expense is primarily due to increase in salaries and benefits, consulting, office and general expenses and stock based compensation, offset by decrease in professional fees.
Salaries and benefits for the nine months ended September 30, 2026 and 2025, comprise primarily compensation of our officers, directors, and contractor of $238,500 and $212,917, respectively.
During the nine months ended September 30, 2026 and
2025, consulting expenses of $539,143 and $101,458 consisted of costs related to the development of new businesses including consulting
fees paid to Ujjwal Roy,
ExtangleX build out costs and Extangle X monthly operating costs.
Professional fees comprise legal fees from compliance and the review of proposed transactions and debt agreements, annual audit and filling fees.
Stock-based compensation - services for the nine months ended September 30, 2026 and 2025, comprise primarily compensation of our contractors of $773,415 and $0, respectively.
Other income (expense):
| Nine months ended September 30, | Change | |||||||||||||||
| 2026 $ | 2025 $ | $ | % | |||||||||||||
| Amortization of debt discount and interest expense | (230,595 | ) | (321,941 | ) | 91,346 | (28 | ) | |||||||||
| Gain (loss) on settlement of non-redeemable convertible notes and promissory notes | 5,272 | (17,181 | ) | 22,453 | (131 | ) | ||||||||||
| Initial derivative expense | (33,804 | ) | (235,220 | ) | 201,416 | (86 | ) | |||||||||
| Change in fair value of derivative liabilities | 219,239 | 215,904 | 3,335 | 2 | ||||||||||||
| Write-off of advances | (15,992 | ) | — | (15,992 | ) | |||||||||||
| Total other income (expenses) | (55,880 | ) | (358,438 | ) | 302,558 | (84 | ) | |||||||||
| 24 |
Amortization of debt discount and interest expense for the nine months ended September 30, 2026 was $230,595, compared to $321,941 for the nine months ended September 30, 2025. Amortization of debt discount and interest expense relates to the issuance of non- redeemable convertible notes, convertible notes and promissory notes. During the year ended December 31, 2025, the Company issued shares of common to stock to settle convertible notes, promissory notes and a line of credit which resulted in a decrease in amortization of debt discount and interest expense during nine months ended September 30, 2026.
Initial derivative expense of $33,804 for the nine months ended September 30, 2026 represents the difference between the fair value of the total embedded derivative liability of $113,804 and the cash received of $80,000 for convertible note issued on January 16, 2026 .
Gain on debt settlement for the nine months ended September 30, 2026 of $5,272, is comprised of the difference between the carrying value of convertible promissory notes, net and derivative liabilities settled of $279,760 and the cash paid of $274,488 for convertible notes issued on November 13, 2025 and December 2, 2025.
Net loss for the period:
| Nine months ended September 30, | Change | |||||||||||||||
| 2026 $ | 2025 $ | $ | % | |||||||||||||
| Net loss for the period | (2,927,672 | ) | (1,083,086 | ) | (1,844,587 | ) | 170 | |||||||||
Our net loss for the nine months ended September 30, 2026 was $2,927,672, compared to $1,083,086 for the nine months ended September 30, 2025, respectively. Our losses during the nine months ended September 30, 2026 and 2025 are primarily due to costs associated with compensation to our officers and directors, consulting, professional fees, interest, and change in fair value of derivative liabilities.
QUARTERLY RESULTS OF OPERATIONS
The following is a summary of selected quarterly information that has been derived from the financial statements of the Company. This summary should be read in conjunction with the consolidated financial statements of the Company.
| Quarter Ended | September 30, 2026 | June 30, 2026 | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | ||||||||||||||||||||||||
| Sales | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | 140,258 | ||||||||||||||||
| Gross profit | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | (34,216 | ) | |||||||||||||||
| Operating expenses | $ | (559,674 | ) | $ | (2,076,433 | ) | $ | (235,686 | ) | $ | (332,678 | ) | $ | (259,977 | ) | $ | (207,602 | ) | $ | (257,069 | ) | $ | (299,791 | ) | ||||||||
| Other income (expense) | $ | (117,355 | ) | $ | (109,976 | ) | $ | 171,452 | $ | 930,910 | $ | (156,359 | ) | $ | (128,716 | ) | $ | (73,363 | ) | $ | (489,659 | ) | ||||||||||
| Net income (loss) for the period | $ | (677,029 | ) | $ | (2,186,409 | ) | $ | (64,234 | ) | $ | 598,232 | $ | (416,336 | ) | $ | (336,318 | ) | $ | (330,432 | ) | $ | (823,666 | ) | |||||||||
| Basic and diluted net income (loss) per share | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | ||||||||
| 25 |
LIQUIDITY AND CAPITAL RESOURCES
For the nine months ended September 30, 2026
Cash flows used in operating activities
| Nine months ended September 30, | Change | |||||||||||||||
| 2026 $ | 2025 $ | $ | % | |||||||||||||
| Net cash used in operating activities | (868,710 | ) | (492,840 | ) | (375,870 | ) | 76 | |||||||||
Our net cash used in operating activities for the nine months ended September 30, 2026 and 2025 is $860,710 and $492,840, respectively. Our net loss for the nine months ended September 30, 2026 of $2,927,672 and change in fair value of derivative liabilities of $219,239 was the main contributing factors for our negative cash flow. We were able to partially offset the cash used in operating activities with non-cash expenses such as stock-based compensation, amortization of debt discount and initial derivative expense.
Cash flows used in investing activities
| Nine months ended September 30, | Change | |||||||||||
| 2026 $ | 2025 $ | $ | ||||||||||
| Net cash used in investing activities | (387,879 | ) | — | (367,879 | ) | |||||||
Our net cash used in investing activities for the nine months ended September 30, 2026 and 2025 is $387,879 and $0, respectively. During the nine months ended September 30, 2026, we purchased of graphics processing unit we made deposits on contractual commitments related to our More Money, EntangleX and DailyLove projects and capitalized software development costs related to our Scalova project.
Cash flows from financing activities
| Nine months ended September 30, | Change | |||||||||||||||
| 2026 $ | 2025 $ | $ | % | |||||||||||||
| Net cash provided by financing activities | 1,108,512 | 500,688 | 607,824 | 121 | ||||||||||||
Our net cash provided by financing activities for the nine months ended September 30, 2026 and 2025, is $1,108,512 and $500,688, respectively.
During the nine months ended September 30, 2026 and 2025, the Company received cash advances from related party of $998,000 and $428,100, respectively. These cash advances earns interest at 8% per annum, is unsecured and is due on demand.
As of September 30, 2026, we had cash of $79,508, working capital (deficiency) of $(3,065,331) and total liabilities of $3,317,475.
Our working capital as of September 30, 2026 and December 31, 2025 is as follows:
| September 30, 2026 | December 31, 2025 | |||||||
| Current assets | $ | 246,160 | $ | 254,236 | ||||
| Current liabilities | 3,311,491 | 2,264,701 | ||||||
| Working capital (Deficiency) | $ | (3,065,331 | ) | $ | (2,010,465 | ) | ||
| 26 |
The Company is continuing to focus improving cash flows from operations reducing expenses, managing accounts payable balances and by paying our officers, directors, consultants and staff with our stock.
The Company’s financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. During the nine months ended September 30, 2026, the Company incurred a net loss of $2,927,672 and used cash in operating activities of $868,710, and on September 30, 2026, had stockholders’ deficit of $2,631,455 and an accumulated deficit of $97,932,674. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. The Company’s independent registered public accounting firm, in their report on the Company’s financial statements for the year ended December 31, 2025, contains an explanatory paragraph regarding the Company’s ability to continue as a going concern. The Company’s financial statements do not include any adjustments that might result from the outcome of this uncertainty should we be unable to continue as a going concern.
Over the next 12 months we expect to spend approximately $1,070,000 in cash for operations, legal, accounting, and related services and to implement our business plan. We hope to be able to compensate our independent contractors with stock-based compensation, which will not require us to use our cash, although there can be no assurances that we will be successful in these efforts.
| Cash Required to Implement of Business Plan | ||
| General and Administration | $ | 300,000 |
| Scalova/EntangleX buildout and monthly operating costs (Note 8) | 520,000 | |
| DailyLove agreement (Note 10) | 250,000 | |
| Total Estimated Cash Expenditures | $ | 1,070,000 |
We expect to be able to secure additional capital through advances from our Chief Executive Officer in order to pay expenses such as organizational costs, filing fees, accounting fees and legal fees, however, we do not have any written or oral agreements with any other third parties which require them to fund our operations. We are currently in discussions with investors for private loans and an equity line of credit. Although there can be no assurances that we will be able to obtain such funds in the future, the Company has been able to secure financing to continue operations since its inception on April 3, 2009. We are currently quoted on OTC Pink.. If we need additional capital in the next twelve months and if we cannot raise such capital on acceptable terms, we may have to curtail our operations or terminate our business entirely.
The inability to obtain financing or generate sufficient cash from operations could require us to reduce or eliminate expenditures for developing products and services, or otherwise curtail or discontinue our operations, which could have a material adverse effect on our business, financial condition and results of operations. Furthermore, to the extent that we raise additional capital through the sale of equity or convertible debt securities, the issuance of such securities may result in dilution to existing stockholders. If we raise additional funds through the issuance of debt securities, these securities may have rights, preferences and privileges senior to holders of our common stock and the terms of such debt could impose restrictions on our operations. Regardless of whether our cash assets prove to be inadequate to meet our operational needs, we may seek to compensate providers of services by issuing stock in lieu of cash, which may also result in dilution to existing stockholders.
Our common stock started trading over the counter and has been quoted on the Over-The Counter Bulletin Board since February 17, 2011. The stock currently trades under the symbol “QUTX”.
Commitments for future capital expenditures at September 30, 2026 is as follows:
| Payments Due by Period | ||||||||||||||||||||
| Contractual obligations | Total $ | Less than 1 year $ | 1 - 3 years $ | 4 – 5 years $ | After 5 years $ | |||||||||||||||
| Accounts payable and accrued liabilities | 749,579 | 749,579 | — | — | — | |||||||||||||||
| Debt | 2,074,513 | 2,074,513 | — | — | — | |||||||||||||||
| Non-redeemable convertible notes | 137,951 | 137,951 | — | — | — | |||||||||||||||
| Convertible promissory notes, net | 135,948 | 135,948 | — | — | — | |||||||||||||||
| Derivative liabilities | 213,500 | 213,500 | — | — | — | |||||||||||||||
| Operating leases | — | — | — | — | — | |||||||||||||||
| Total contractual obligations | 3,311,491 | 3,311,491 | — | — | — | |||||||||||||||
| 27 |
OPERATING CAPITAL AND CAPITAL EXPENDITURE REQUIREMENTS
We expect to be able to secure additional capital through advances from our Chief Executive Officer in order to pay expenses such as organizational costs, filing fees, accounting fees and legal fees, however, we do not have any written or oral agreements with any other third parties which require them to fund our operations. We are currently in discussions with investors for private loans and an equity line of credit. Although there can be no assurances that we will be able to obtain such funds in the future, the Company has been able to secure financing to continue operations since its inception on April 3, 2009. We are currently quoted on OTC Pink. If we need additional capital in the next twelve months and if we cannot raise such capital on acceptable terms, we may have to curtail our operations or terminate our business entirely.
Our common stock started trading over the counter and has been quoted on the Over-The Counter Bulletin Board since February 17, 2011. The stock currently trades under the symbol “QUTX”.
RELATED PARTY TRANSACTIONS
Nine months ended September 30, 2026 and 2025
Non-redeemable Convertible Notes – Related Party
On September 13, 2018, the Company entered into a Side Letter Agreement (“Original Note”) with a non-related investor, Jordan Turk, to amend and add certain terms to unsecured, non-interest bearing, due on demand notes payable totaling $40,000 issued by the Company during the period of July 10, 2018 to September 13, 2018. The issue price of the Note is $40,000 with a face value of $48,000 and the Note has an original maturity date of December 31, 2018 which is subject to automatic annual renewal. On June 29, 2021, the Company and Jordan Turk entered into an Agreement to change the original maturity date of the Note to December 31, 2025. At the option of the Company, the Company may convert principal and interest at a fixed conversion price of $0.0001 per share of the Company’s common stock. The Note allows the lender to secure a portion of the Company assets up to 200% of the face value of the Note. If the Note is not paid on December 31 each year, the outstanding face amount of the Note increases by 20% on January 1 the following year.
On December 30, 2024, Jordan Turk and the Company agreed to exchange $43,328 of principal and interest of Original Note for a New Promissory Note with a carrying value of $71,993 resulting in a loss of extinguishment of $28,665.
Also, on December 30, 2024, Jordan Turk entered into an agreement to assign the remaining outstanding principal and interest of the Original Note with a carrying value of $100,000 to Emil Assentato, the Chief Executive Officer of the Company.
The consolidated statement of operations includes amortization of debt discount of $17,951 and $14,959 for the nine months ended September 30, 2026 and 2025, respectively, due to the 20% increase in face value on January 1 each year. On September 30, 2026 and December 31, 2025, the carrying amount of the Note is $137,951 (face value of $144,000 less $6,049 unamortized discount) and $120,000 (face value of $120,000 less $0 unamortized discount), respectively.
| 28 |
Promissory Notes – Related Party
On September 30, 2026 and December 31, 2025, $1,959,777 (comprising of $1,851,100 of advances and $108,677 of interest) and $882,632 (comprising of $853,100 of advances and $29,532 of interest), respectively was due to Emil Assentato, the Company's Chief Executive. During nine months ended September 30, 2026, the Company issued total advances for $998,000 comprising $998,000 for cash received and $0 of expenses paid on behalf of the Company. This note payable – related party earns interest at 8% per annum, is unsecured and is due on demand.
Software Development Agreement
On May 1, 2026, the Company entered into a contract with Ujjwal Roy, the Head of Strategy of the Company, to (a) complete the build-out of the user face for EntangleX and (b) provide ongoing maintenance, operations, marketing, sales, and engineering services (“monthly operating costs”) to EntangleX and Scalova. The Company is committed to $250,000 in expenditures for the EntangleX build-out project which is expected to be completed in three months. The Company is also committed to an estimated $35,000 of monthly operating costs for the support of EntangleX and Scalova ($20,000 for EntangleX and $15,000 for Scalova). Pursuant to the provisions of ASC 985-20, all payments made during the period under this agreement to Ujjwal Roy ($150,000 for EntangleX and $140,000 in operating costs) have been deemed research and development, which we have recorded in general and administrative expense on the condensed consolidated statements of operations and comprehensive income (loss).
Our policy with regard to transactions with related persons or entities is that such transactions must be on terms no less favorable than could be obtained from non-related persons.
The above related party transactions are not necessarily indicative of the amounts that would have been incurred had a comparable transaction been entered into with an independent party.
PROPOSED TRANSACTIONS
The Company is not anticipating any transactions.
CHANGES IN ACCOUNTING POLICIES INCLUDING INITIAL ADOPTION
Refer to Note 2 in the consolidated financial statements for the year ended December 31, 2025 for information on accounting policies.
FINANCIAL INSTRUMENTS
The main risks of the Company’s financial instrument are exposed to are credit risk, market risk, foreign exchange risk, and liquidity risk.
Credit risk
The Company’s credit risk is primarily attributable to trade receivables. The Company mitigates credit risk through approvals, limits and monitoring. The amounts disclosed in the consolidated balance sheet are net of allowances for expected credit losses, estimated by the Company’s management based on past experience and specific circumstances of the customer. The Company manages credit risk for cash by placing deposits at major financial institutions.
Market risk
Market risk is the risk that changes in market prices and interest rates will affect the Company’s net earnings or the value of financial instruments. These risks are generally outside the control of the Company. The objective of the Company is to mitigate market risk exposures within acceptable limits, while maximizing returns. The Company’s market risk consists of risks from changes in foreign exchange rates, interest rates and market prices that affect its financial liabilities, financial assets and future transactions.
Refer to Note 2 in the consolidated financial statements for the year ended December 31, 2025 and Note 2 in the consolidated financial statements for the year ended December 31, 2025 for information on market risk.
Foreign Exchange risk
We pay expenses in Canadian dollars from operations in Canada. Our consolidated financial statements are presented in U.S. dollars and our liabilities other than trade payables are primarily due in U.S. dollars.
| 29 |
Liquidity risk
Liquidity risk relates to the risk the Company will encounter difficulty in meeting its obligations associated with financial liabilities. The financial liabilities on our consolidated balance sheets consist of accounts payable and accrued liabilities, due to related party, notes payable, convertible notes, net, derivative liabilities, promissory notes, promissory notes – related party and non-redeemable convertible notes, Management monitors cash flow requirements and future cash flow forecasts to ensure it has access to funds through its existing cash and from operations to meet operational and financial obligations
OUTSTANDING SHARE DATA
As of November 11, 2026, the following securities were outstanding:
Common stock 7,697,746,967 shares
OFF-BALANCE SHEET TRANSACTIONS
We currently have no off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
As a Smaller Reporting Company, as defined by Rule 12b-2 of the Exchange Act and in Item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this Item.
ITEM 4. CONTROLS AND PROCEDURES
EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES
As required by Rule 13a-15 of the Securities Exchange Act of 1934, our principal executive officer and principal financial officer evaluated our company's disclosure controls and procedures (as defined in Rules 13a-15(e) of the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based on this evaluation, our principal executive officer and principal financial officer concluded that as of the end of the period covered by this report, these disclosure controls and procedures were not effective to ensure that the information required to be disclosed by our company in reports it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities Exchange Commission and to ensure that such information is accumulated and communicated to our company's management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure. The conclusion that our disclosure controls and procedures were not effective was due to the presence of the following material weaknesses in internal control over financial reporting which are indicative of many small companies with small staff: (i) inadequate segregation of duties and effective risk assessment; and (ii) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of both United States generally accepted accounting principles and Securities and Exchange Commission guidelines. Management anticipates that such disclosure controls and procedures will not be effective until the material weaknesses are remediated.
We plan to take steps to enhance and improve the design of our internal controls over financial reporting. During the period covered by this quarterly report on Form 10-Q, we have not been able to remediate the material weaknesses identified above. To remediate such weaknesses, we plan to implement the following changes during our fiscal year ending December 31, 2026, subject to obtaining additional financing: (i) appoint additional qualified personnel to address inadequate segregation of duties and ineffective risk management; and (ii) adopt sufficient written policies and procedures for accounting and financial reporting. The remediation efforts set out above are largely dependent upon our securing additional financing to cover the costs of implementing the changes required. If we are unsuccessful in securing such funds, remediation efforts may be adversely affected in a material manner.
Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake.
CHANGES IN INTERNAL CONTROLS OVER FINANCIAL REPORTING
There were no changes in our internal control over financial reporting during the quarter ended September 30, 2026 that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.
| 30 |
PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS.
We may be involved from time to time in ordinary litigation, negotiation and settlement matters that will not have a material effect on our operations or finances. We are not aware of any pending or threatened litigation against our Company or our officers and directors in their capacity as such that could have a material impact on our operations or finances.
ITEM 1A. RISK FACTORS
A smaller reporting company is not required to provide the information required by this Item.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
During the nine months ended September 30, 2026, the Company issued an aggregate of 478,289,474 shares of the Company’s common stock with a fair value of $957,500 ($0.002 per share) pursuant to the Company’s 2026 Stock Incentive Plan. The shares were issued to certain officers, directors and consultants of the Company in consideration for services rendered pursuant to the terms of the Plan and applicable award agreements.
During the nine months ended September 30, 2026, the Company issued an aggregate of 315,000,000 shares of the Company’s common stock with a fair value of $625,000 ($0.002 per share) for services pursuant to the Company’s 2026 Stock Incentive Plan.
During the nine months ended September 30, 2026, the Company issued 210,000,000 shares of common stock of the Company for consulting and corporate advisory services with a fair value of $283,000 ($0.0013 per share) which was included in prepaid expenses. Prepaid expenses are amortized over periods from nine months to twelve months.
During the nine months ended September 30, 2026, the Company returned to treasury and cancelled 77,627,224 shares of common stock.
During the nine months ended September 30, 2026, the Company issued 134,210,526 shares of the Company’s common stock with a fair value of $255,000 ($0.0019 per share) pursuant to the Company’s 2026 Stock Incentive Plan to settle accrued liabilities – related party due to Emil Assentato, the Chief Executive Officer of the Company.
During the nine months ended September 30, 2026, the Company issued 136,364,500 shares of the Company’s common stock with a fair value of $168,103 ($0.0012 per share) for conversion of the convertible promissory notes. The conversions resulted in the settlement of derivative liabilities of $58,700 and a loss on settlement of debt of $66,184.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES.
During the quarter ended September 30, 2026, we did not have any defaults upon senior securities.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION.
During the quarter ended September 30, 2026, no director or Section 16
officer
| 31 |
ITEM 6. EXHIBITS
| Incorporated by reference | ||||||
| Exhibit | Exhibit Description | Filed herewith | Form | Period ending | Exhibit | Filing date |
| 3.1 | Certificate of Incorporation, dated April 3, 2009 | S-1 | 3.1 | 6/22/2010 | ||
| 3.2 | Bylaws, dated April 3, 2009 | S-1 | 3.2 | 6/22/2010 | ||
| 3.3 | Certificate of Amendment to the Certificate of Incorporation, dated August 8, 2013 | 10-Q | 6/30/2013 | 3.3 | 8/14/2013 | |
| 3.4 | Certificate of Amendment to the Certificate of Incorporation, dated July 27, 2016 | 8-K | 9/1/2016 | 3.1 | 9/1/2016 | |
| 3.5 | Certificate of Amendment to the Certificate of Incorporation, dated August 27, 2018 | 8-K | 9/10/2018 | 3.1 | 9/10/2018 | |
| 3.6 | Certificate of Amendment to the Certificate of Incorporation, dated November 18, 2019 | 8-K | 12/12/2019 | 3.1 | 12/12/2019 | |
| 3.7 | Certificate of Amendment to the Certificate of Incorporation, dated July 16, 2021 | 8-K | 7/16/2021 | 3.1 | 7/22/2021 | |
| 3.8 | Certificate of Amendment to the Certificate of Incorporation, dated January 3, 2022 | 8-K | 1/3/2022 | 3.1 | 1/6/2022 | |
| 3.9 | Certificate of Amendment to the Certificate of Incorporation, As Amended, dated March 21, 2022 |
8-K | 4/25/2022 | 3.1 | 4/26/2022 | |
| 3.10 | Certificate of Amendment to the Certificate of Incorporation, As Amended, filed with the Delaware Secretary of State on August 22, 2023. |
8-K | 9/8/2023 | 3.1 | 9/11/2023 | |
| 4.1 | Specimen Stock Certificate | S-1 | 4.1 | 6/22/2010 | ||
| 4.2 | Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock, dated August 6, 2013 | 10-Q | 6/30/2013 | 4.2 | 8/14/2013 | |
| 4.3 | Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock, dated December 12, 2019 | 8-K
|
12/12/2019
|
3.1
|
12/19/2019
| |
| 4.4 | Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock, dated October 7, 2020 | 8-K | 10/07/2020 | 3.1 | 10/08/2020 | |
| 4.5 | Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock, dated June 24, 2021 | 8-K | 6/24/2021 | 3.1 | 7/1/2021 | |
| 4.6 | Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock, dated September 1, 2021 | 8-K | 9/1/2021 | 3.1 | 9/1/2021 | |
| 4.7 | Amended and Restated Designation of Series A Convertible Preferred Stock of Two Hands Corporation, dated April 21, 2022 | 8-K | 4/21/2022 | 3.1 | 4/26/2022 | |
| 4.8 | Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock, dated July 5, 2022 | 10-Q | 6/30/2022 | 4.8 | 8/15/2022 | |
| 4.9 | Certificate of Designation, Preference and Rights of Series E Preferred Stock, dated October 3, 2022 | 8-K | 10/4/2022 | 3.1 | 10/11/2022 | |
| 10.1 | Innovative Product Opportunities Inc. Trust Agreement | S-1 | 10.1 | 6/22/2010 | ||
| 10.2 | Side Letter Agreement, The Cellular Connection Ltd., dated January 8, 2018 | 10-K | 12/31/2017 | 10.2 | 3/29/2018 | |
| 10.3 | Side Letter Agreement, Stuart Turk, dated January 8, 2018 | 10-K | 12/31/2017 | 10.3 | 3/29/2018 | |
| 10.4 | Side Letter Agreement, Jordan Turk, dated April 12, 2018 | 10-Q | 3/31/2018 | 10.4 | 5/21/2018 | |
| 10.5 | Side Letter Agreement, Jordan Turk, dated May 10, 2018 | 10-Q | 3/31/2018 | 10.5 | 5/21/2018 | |
| 10.6 | Side Letter Agreement, Jordan Turk, dated September 13, 2018 | 10-K | 12/31/2018
|
10.6 | 4/1/2019 | |
| 10.7 | Side Letter Agreement, The Cellular Connection Ltd., dated January 31, 2019 | 10-K | 12/31/2018 | 10.7 | 4/1/2019 | |
| 10.8 | Side Letter Agreement, Stuart Turk, dated January 31, 2019 | 10-K | 12/31/2018 | 10.8 | 4/1/2019 | |
| 19.1 | Insider Trading Policy | 10-K | 12/31/2024 | 19.1 | 4/14/2025 | |
| 31.1 | Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 31.2 | Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 32.1* | Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 32.2* | Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 101.INS | XBRL Instance Document – the instance document does not appear in the Interactive Data Files as its XBRL tags are embedded within the Inline XBRL document | X | ||||
| 101.SCH | XBRL Taxonomy Extension Schema Document | X | ||||
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | X | ||||
| 101.LAB | XBRL Taxonomy Extension Label Linkbase Document | X | ||||
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document | X | ||||
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Definition | X | ||||
| 104 | Cover page formatted as Inline XBRL and contained in Exhibit 101 | X | ||||
Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability under those sections.
| 32 |
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| QUANTUM X, INC. | ||
| Dated: November 16, 2026 |
By: /s/ Emil Assentato Name: Emil Assentato Title: President, Chief Executive Officer and Director (Principal Executive Officer) | |
|
By: /s/ Matthew Stark Name: Matthew Stark Title: Chief Financial Officer and Director (Principal Financial and Accounting Officer) | ||
| 33 |